MedTrace Logo

INternational ORthopaedic MUlticenter Study in Fracture Care (INORMUS)

NCT02150980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39797

Last updated 2024-06-06

No results posted yet for this study

Summary

Background: Worldwide, injuries from trauma represent a major public health problem. The World Health Organization (WHO) has deemed this problem as one of the most important global priorities, calling 2011-2020 the 'Decade of Action for Road Safety'. Despite this, there is little empirical data in low and middle-income countries quantifying the burden of musculoskeletal injuries.

Methods: INORMUS is a global, prospective, multi-center, observational cohort study. The primary objective of the study is to determine the mortality, re-operation and infection rates of musculoskeletal trauma patients within 30 days post-hospital admission. The INORMUS study seeks to enroll 40,000 patients from low-middle income countries in Africa, Asia, and Latin America.

Conditions

  • Fractures or Dislocations

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • McMaster Surgical Associates

    collaborator OTHER

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • Hamilton Health Sciences Corporation

    collaborator OTHER

  • McMaster University

    lead OTHER

Principal Investigators

  • Mohit Bhandari, MD, PhD · McMaster University

  • Philip Devereaux, MD, PhD · McMaster University

  • Rebecca Ivers, MPH, PhD · The George Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Argentina
  • Botswana
  • Brazil
  • Cameroon
  • China
  • Colombia
  • Ethiopia
  • Ghana
  • India
  • Iran
  • Kenya
  • Malawi
  • Mexico
  • Nepal
  • Nigeria
  • Pakistan
  • Panama
  • Paraguay
  • Philippines
  • Rwanda
  • South Africa
  • Tanzania
  • Thailand
  • Uganda
  • Venezuela
  • Vietnam

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02150980 on ClinicalTrials.gov